Dr. Ahmara Gibbons Ross, MD, PhD

Dr. Ross practices at Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania.

Dr. Ross' NPI, 1528352804, was assigned on June 4, 2011. Dr. Ross holds Pennsylvania license MD454778.

Dr. Ross' primary practice is Hospital of the University of Pennsylvania, at 3400 Spruce St, Philadelphia, PA 19104 in Philadelphia County. The practice phone is (215) 662-6289.

Dr. Ross' primary practice is Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania, part of University of Pennsylvania. Dr. Ross is also affiliated with Penn Presbyterian Medical Center. The medical group on file is Penn Medicine Lancaster General Health.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ross practices, 2 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Ross' primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dmand AI has Dr. Ross' licenses on file in 2 states: Pennsylvania and New Mexico.

CMS data shows 725 Medicare services from Dr. Ross across 6 procedure codes in 2024, for 238 Medicare patients. Medicare paid $25,064 for them.

CMS counts 238 Medicare patients who saw Dr. Ross in 2024. The largest group is 65 to 74, with 120 patients. 74% of them have high blood pressure, and 74% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.31, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Ross' median patient age at 70, with 60% women.

In 2024, Dr. Ross wrote 1,192 Medicare Part D claims for 265 patients. 80% of them were for generic drugs. CMS names the drug for 1,096 of them, across 12 drugs with 11 or more claims each, at $69,178 in total drug cost. In 2023, CMS named 930 claims across 13 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Ross for performance year 2024, reported as part of a group. Dr. Ross accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 43 procedures of cataract surgery by Dr. Ross, more than 60% of the clinicians it reports for that procedure.

Dmand AI links 36 papers to Dr. Ross, published from 2016 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Retinal Ganglion Cells, Mice, Inbred C57BL and Disease Models, Animal. Dr. Ross has published most often in J Neuroophthalmol. Dr. Ross' most frequent co-authors are Kenneth S. Shindler, MD, Qi N. Cui, MD, PhD and Grant T. Liu, MD.

Dmand AI links Dr. Ross to 1 clinical trial. Conditions studied include Ocular Hypertension and Eye Diseases.

CMS Open Payments shows 15 general payments to Dr. Ross from 7 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 74% of the total. Dompe Farmaceutici S.p.A. paid the most, $2,250.